EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Sepsis-induced ALI/ARDS beyond supportive care: molecular mechanisms and cutting-edge therapies

Muhammad Qasim Barkat, Qiao Li, Majid Manzoor, Chengyun Xu, Nadia Hussain, Ahmad Salawi, Hao Yang, Musaddique Hussain

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115495 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Muhammad Qasim Barkat und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China; Qian Xuesen Collaborative Research Center of Astrochemistry and Spac…. Hauptthemen laut MEDLINE: COVID-19, Sepsis, Respiratory Distress Syndrome, Acute Lung Injury. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 192 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis-induced ALI/ARDS are severe conditions driven by complex molecular and cellular mechanisms, including endothelial dysfunction, immunological dysregulation, epigenetic changes, and oxidative stress. These factors disrupt endothelial integrity and promote cell death, worsening lung injury and respiratory failure. COVID-19-related ARDS, similar to sepsis-induced ALI, is more severe, involving immune dysregulation, cytokine storms, and microthrombi. Despite extensive research, sepsis-induced ALI/ARDS has gained the status of the Bermuda Triangle, as no effective pharmacological treatments are currently available, and supportive therapies remain the mainstay of treatment. Consequently, a critical need exists to explore innovative treatment options. This review highlights the molecular and cellular mechanisms of sepsis-induced ALI/ARDS, key cellular signaling pathways in sepsis-induced ALI/ARDS, clinical insights into COVID-19-related ALI/ARDS, existing and emerging treatments, and the limitations of current therapies. It emphasizes the need for innovative approaches to improve patient outcomes and underscores the importance of advancing research to enhance understanding and treatment development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SepsisRespiratory Distress SyndromeAcute Lung InjuryHumansSARS-CoV-2AnimalsSignal TransductionCytokine Release Syndrome

Stichwörter der Autor:innen

ALIARDSInfectionInflammationSepsis

Autor:innen und Institutionen

  • Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China; Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences at Ningbo University, Ningbo, China.
  • Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
  • Department of Pharmacology, School of Medicine, Hangzhou City University, Hangzhou 311300, China.
  • Department of Pharmaceutical Sciences, College of Pharmacy, Al Ain University, Al Ain, United Arab Emirates; AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.
  • Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
  • Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China. Electronic address: yanghaozunyi@sina.com.

Zitieren

APA

Barkat, M. Q., Li, Q., Manzoor, M., Xu, C., Hussain, N., Salawi, A., Yang, H., & Hussain, M. (2025). Sepsis-induced ALI/ARDS beyond supportive care: molecular mechanisms and cutting-edge therapies. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115495

Vancouver

Barkat MQ, Li Q, Manzoor M, Xu C, Hussain N, Salawi A, et al. Sepsis-induced ALI/ARDS beyond supportive care: molecular mechanisms and cutting-edge therapies. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115495

BibTeX
@article{Barkat2025,
  author = {Barkat, Muhammad Qasim and Li, Qiao and Manzoor, Majid and Xu, Chengyun and Hussain, Nadia and Salawi, Ahmad and Yang, Hao and Hussain, Musaddique},
  title = {Sepsis-induced ALI/ARDS beyond supportive care: molecular mechanisms and cutting-edge therapies},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115495}
}
Kostenlos starten →